Sort
82,697 grants matching “vaccine development”
Mechanisms of IFNg-independent T cell and B cell-mediated protection in TB.
$769,589Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Transmission-blocking potential of novel HIV Env-specific mucosal antibodies
$769,549Sallie R. Permar · Duke University · R01 · FY2015 · AI
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
$769,497Scott C Weaver · University Of Texas Med Br Galveston · R24 · FY2016 · AI
Clinical Trials of Biodefense Vaccines (Dengue)
$769,397Stephen Whitehead · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Deciphering the ontogeny of CD4+ resident memory T cells that globally seed the skin and protect against cutaneous leishmaniasis
$769,366Phillip A. Scott · University Of Pennsylvania · R01 · FY2025 · AI
Modeling Filovirus Infection of and Trafficking through Skin
$769,333Wendy Jean Maury · University Of Iowa · R01 · FY2020 · AI
Effects of obesity on the dynamics of Influenza transmission
$769,323Stacey L Schultz-Cherry · St. Jude Children'S Research Hospital · R01 · FY2019 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients
$769,284Jennifer K. Lodge · Duke University · R01 · FY2025 · AI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine
$769,175Alexander Bukreyev · University Of Texas Med Br Galveston · R01 · FY2020 · AI
Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasites
$769,091Laura J Knoll · University Of Wisconsin-Madison · R01 · FY2023 · AI
Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasites
$769,091Laura J Knoll · University Of Wisconsin-Madison · R01 · FY2025 · AI
Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasites
$769,091Laura J Knoll · University Of Wisconsin-Madison · R01 · FY2024 · AI
Optimizing Oral Pediatric HIV Vaccines to Prevent Breast Milk Transmission
$769,068Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2012 · DE
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
$769,010Yi Shi · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Epigenetics of severe asthma
$769,008Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2020 · HL
Novel delivery platform and antigen design for an effective COVID-19 vaccine
$768,884Suresh K Mittal · Purdue University · R01 · FY2022 · AI
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
$768,859Karen A Norris · University Of Georgia · R01 · FY2022 · AI
Multivalent nanocluster universal influenza vaccine given by microneedle patch
$768,852Baozhong Wang · Georgia State University · R01 · FY2023 · AI
mRNA alternative polyadenylation in B cell development
$768,845Yongsheng Shi · University Of California-Irvine · R01 · FY2025 · AI
Mechanisms of vitamin A-dependent risk for tuberculosis progression and prevention
$768,839Brendan Podell · Colorado State University · R01 · FY2023 · AI
Antisense Mediated Treatment of Hepatitis B Virus Infection
$768,816Urtzi Garaigorta · Scripps Research Institute, The · R01 · FY2015 · AI
HIV and Hepatitis C Pathogenesis & The Human Genome
$768,803David L Thomas · Johns Hopkins University · R01 · FY2014 · DA
Integrative Omics of HepB Vaccine Response in Co-Infection with Parasites
$768,783Elias K Haddad · Drexel University · U19 · FY2019 · AI
VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES
$768,782Howard Tranter · · N01 · FY2018 · AI
Biological Vulnerability to Chlamydia trachomatis in Adolescents and Young Women: the Complex Intersection of Cervicovaginal Microbiome, Cervical Maturation, and Mucosal Immunity
$768,767Loris Y. Hwang · University Of California Los Angeles · R01 · FY2018 · AI